Month: June 2018

CHILD-BRIGHT Network and Ehave Start Enrollment for Cognitive Rehabilitation Trial for Children with ADHD, Autism, and Congenital Heart Disease

OAKVILLE, Ontario, June 28, 2018 /PRNewswire/ — The CHILD-BRIGHT Network, a Canadian patient-oriented research network focussed on pediatric brain-based developmental disorders, and Ehave, Inc. (OTCQB: EHVVF), a healthcare company dedicated to empowering the mental health community with next-generation digital solutions, today announced the start of enrollment for the CHILD-BRIGHT Mega Team research project trial, a Canadian-developed

Continue Reading “CHILD-BRIGHT Network and Ehave Start Enrollment for Cognitive Rehabilitation Trial for Children with ADHD, Autism, and Congenital Heart Disease”

Canada House Wellness Group’s Licensed Cannabis Producer Abba Medix Receives First Sales License from Health Canada

TORONTO, July 23, 2018 (GLOBE NEWSWIRE) — Canada House Wellness Group Inc. (CSE:CHV) (“Canada House” or the “Company”) is pleased to announce that its wholly owned subsidiary, Abba Medix Corp. (“Abba”), a licensed cannabis producer under the Access to Cannabis for Medical Purposes Regulations (the “ACMPR”) has successfully completed its Health Canada pre-sales inspection and

Continue Reading “Canada House Wellness Group’s Licensed Cannabis Producer Abba Medix Receives First Sales License from Health Canada”

FSD Pharma Inc. Welcomes Official Passing of Cannabis Act in Canada

TORONTO, June 22, 2018 /CNW/ – FSD Pharma Inc. (“FSD” or the “Company”) (CSE:HUGE), welcomes the official passing of Bill C-45, the Cannabis Act in Canada.

FSD Pharma Inc. Announces Appointment of Chief Commercial Officer

TORONTO, June 21, 2018 /CNW/ – Thomas Fairfull, President and Chief Executive Officer of FSD Pharma Inc. (“FSD” or the “Company”) (CSE:HUGE), is pleased to announce the appointment of Mr. Michael Ash as the Chief Commercial Officer of FV Pharma Inc. (“FV Pharma”), a wholly-owned subsidiary of the Company.

FSD Pharma Inc. Announces a Partnership Agreement with Cannara Biotech Inc. to Allow for Indoor Grow Space to Increase to a Combined 1,245,000 Square Feet

TORONTO, June 19, 2018 /CNW/ – FSD Pharma Inc. (“FSD Pharma” or “The Company”) (CSE:HUGE), announced the signing of a partnership agreement between FV Pharma Inc. (“FV Pharma”), a wholly-owned subsidiary of the Company, and Cannara Biotech Inc. (“Cannara”) effective May 31, 2018. The agreement creates the ability for the Company to  become the largest

Continue Reading “FSD Pharma Inc. Announces a Partnership Agreement with Cannara Biotech Inc. to Allow for Indoor Grow Space to Increase to a Combined 1,245,000 Square Feet”

NuRAN Wireless and Avanti Communications Sign Partnership Agreement

QUEBEC CITY, June 19, 2018 (GLOBE NEWSWIRE) — NuRAN Wireless Inc. (“NuRAN Wireless” or the “Company”) (CSE:NUR) (OTC:NRRWF) (FSE:1RN) is pleased to announce that it has signed an MOU with Avanti Communications Group plc (“Avanti”), [AIM (AVN:LSE)] to market and distribute a combined 2G RAN product alongside Avanti’s Ka-band satellite backhaul solution.